Eyepoint Price To Sales Ratio from 2010 to 2024

EYPT Stock  USD 7.94  0.31  3.76%   
Eyepoint Pharmaceuticals Price To Sales Ratio yearly trend continues to be comparatively stable with very little volatility. Price To Sales Ratio will likely drop to 18.09 in 2024. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Eyepoint Pharmaceuticals' market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
19.03859533
Current Value
18.09
Quarterly Volatility
79.34853682
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eyepoint Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eyepoint Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 440.8 K, Interest Expense of 1.6 M or Total Revenue of 48.3 M, as well as many indicators such as Price To Sales Ratio of 18.09, Dividend Yield of 0.0 or PTB Ratio of 3.13. Eyepoint financial statements analysis is a perfect complement when working with Eyepoint Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Eyepoint Pharmaceuticals Correlation against competitors.
For more information on how to buy Eyepoint Stock please use our How to Invest in Eyepoint Pharmaceuticals guide.

Latest Eyepoint Pharmaceuticals' Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Eyepoint Pharmaceuticals over the last few years. Price to Sales Ratio is figured by comparing Eyepoint Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Eyepoint Pharmaceuticals sales, a figure that is much harder to manipulate than other Eyepoint Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Eyepoint Pharmaceuticals' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eyepoint Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 12.32 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Eyepoint Price To Sales Ratio Regression Statistics

Arithmetic Mean38.44
Geometric Mean15.30
Coefficient Of Variation206.44
Mean Deviation40.07
Median13.62
Standard Deviation79.35
Sample Variance6,296
Range317
R-Value(0.50)
Mean Square Error5,110
R-Squared0.25
Significance0.06
Slope(8.81)
Total Sum of Squares88,147

Eyepoint Price To Sales Ratio History

2024 18.09
2023 19.04
2022 3.15
2021 9.53
2020 2.45
2018 7.94
2017 32.47

About Eyepoint Pharmaceuticals Financial Statements

Eyepoint Pharmaceuticals shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Eyepoint Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Eyepoint Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Eyepoint Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price To Sales Ratio 19.04  18.09 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eyepoint Stock Analysis

When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.